Valuation: AcouSort AB

Market Cap 55.24M 5.47M 4.97M 4.59M 4.15M 7.83M 514M 8.11M 21.89M 276M 20.53M 20.1M 873M P/E 2026 *
-
P/E 2027 * -
Enterprise Value 55.24M 5.47M 4.97M 4.59M 4.15M 7.83M 514M 8.11M 21.89M 276M 20.53M 20.1M 873M EV / Sales 2026 *
5.58x
EV / Sales 2027 * 3.73x
Free-Float
70.68%
Yield 2026 *
-
Yield 2027 * -
1 day-3.33%
1 week-16.35%
Current month-18.94%
1 month-14.71%
3 months-15.26%
6 months-45.51%
Current year-7.77%
1 week 2.25
Extreme 2.25
3
1 month 2.25
Extreme 2.25
3.68
Current year 2.03
Extreme 2.03
5.16
1 year 2.03
Extreme 2.03
5.16
3 years 2.03
Extreme 2.03
20.8
5 years 2.03
Extreme 2.03
32.95
10 years 2.03
Extreme 2.03
32.95
Manager TitleAgeSince
Chief Executive Officer 68 01/01/2014
Director of Finance/CFO 65 01/01/2016
Director TitleAgeSince
Director/Board Member 64 01/01/2012
Chairman 65 01/01/2011
Director/Board Member - 01/12/2021
Change 5-day change 1-year change 3-year change Capi.($)
-3.33%-16.35%+0.77%-82.77% 5.47M
-1.29%-3.91%+51.98%+69.06% 65.56B
-0.09%+2.79%+12.54%+95.02% 60.41B
+0.63%+1.64%+23.11%+89.70% 55.76B
-1.26%-1.45%+12.43%+117.42% 46.98B
-0.15%-5.06%+20.00%+29.27% 43.63B
-3.15%-16.63%+146.30%+685.27% 36.09B
+0.23%+2.14%+14.85%+46.22% 36.7B
+2.35%-3.61%+80.65%+60.70% 32.9B
+1.42%+5.84%-36.40%+402.78% 26.96B
Average -0.46%-3.11%+32.62%+151.27% 40B
Weighted average by Cap. -0.27%-1.58%+35.58%+151.48%

Financials

2026 *2027 *
Net sales 9.9M 981K 891K 823K 744K 1.4M 92.09M 1.45M 3.92M 49.42M 3.68M 3.6M 157M 14.8M 1.47M 1.33M 1.23M 1.11M 2.1M 138M 2.17M 5.86M 73.88M 5.5M 5.39M 234M
Net income - -
Net Debt - -
Projected Income Statement - Annual - AcouSort AB
Logo AcouSort AB
Acousort AB is a Sweden-based company engaged in the medical technology. The Company develops, produces and sells standalone laboratory products and integrated original equipment manufacturer (OEM) solutions where ultrasound is used to separate, wash and enrich cells, exosomes and other biological particles for research and diagnostics. Its product portfolio includes AcouWash and AcouTrap that are targeting separation, washing and enrichment applications within cell, bacteria and extracellular vesicle research. In addition, the Company develops proprietary bioanalytical and clinical applications based on acoustophoresis, and offers custom-developed acoustophoresis applications.
Employees
11
Date Price Change Volume
16/11/26 SEK 2.610 -3.33% 46,062
13/11/26 SEK 2.700 +15.38% 154,208
12/11/26 SEK 2.340 -19.86% 135,062
11/11/26 SEK 2.920 -2.67% 22,377
10/11/26 SEK 3.000 -3.85% 9,140

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - AcouSort AB
  1. Stock Market
  2. Stocks
  3. ACOU Stock